tiprankstipranks
Trending News
More News >
Teva Pharmaceutical (TEVA)
NYSE:TEVA
US Market

Teva Pharmaceutical (TEVA) Cash flow

Compare
7,627 Followers

Teva Pharmaceutical Cash Flow

TEVA's free cash flow for Q3 2025 was $233.00M. For the 2025 fiscal year, TEVA's free cash flow was decreased by $1.21B and operating cash flow was $369.00M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ 2.55B$ 1.37B$ 1.59B$ 798.00M$ 1.22B
Investing Cash Flow
$ -565.67M$ 968.00M$ 656.00M$ 1.52B$ 863.00M
Financing Cash Flow
$ -1.74B$ -1.91B$ -1.49B$ -2.17B$ -1.89B
End Cash Position
$ 3.30B$ 3.23B$ 2.83B$ 2.20B$ 2.18B
Free Cash Flow
$ 2.05B$ 842.00M$ 1.04B$ 236.00M$ 638.00M
Currency in USD

Teva Pharmaceutical Cash Flow